Author

Daniel Schnepf

University of FreiburgORCID 0000-0002-7528-981XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Alison V. TurneriD· 1 shared Alistair J. HenryiD· 1 shared Andrew G. Popplewell· 1 shared ANDREZA ESTEFANY DA SILVA OLIVEIRAiD· 1 shared Anna Laura CalvaneseiD· 1 shared Annelies Van HeckeiD· 1 shared Annette OhnemusiD· 1 shared Bert SchepensiD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alison V. TurnerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyEuropean Journal of ImmunologyPeer-reviewedJul 9, 2024

Sustained innate interferon is an essential inducer of tertiary lymphoid structures

Anna Laura Calvanese, Virginia Cecconi, Severin Stäheli…·Maries F. van den Broek

This study identifies sustained type I interferon signaling as essential for the development of functional tertiary lymphoid structures in the lungs during inflammation.

32 citationstop 4%

mouseexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 8, 2021

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

7 citations

mouserat

𝕏 PostBluesky